Join CBBS   |   Print Page   |   Contact Us   |   Report Abuse   |   Sign In
Annual Meeting 2017 - Educational Session Details
Share |


4:15 p.m. - 5:15 p.m. 


Based on his experience as an insider at famed Southwest Airlines and consultant to dozens of other Fortune 500 companies, Jason Young offers a dramatically different approach to creating and sustaining a high performance workplace. His solution for companies is to create an organizational culture where employees can do their best work and one that will produce the desired performance outcomes in productivity, profitability, employee retention and customer satisfaction. The key is intentionally identifying and developing the essential factors that impact performance for any organization: leadership principles, management practices, team alignment and employee behavior. These are the elements that truly define organizational culture and that have the greatest impact on results.



8 a.m. - 8:30 a.m. 

Pre-Ledin Lecture: Hemovigilance Definitions of Transfusion Reactions: Case Studies. Morvarid Moayeri, MD, PhD (UCSF)

In order to improve the reporting, monitoring and understanding of transfusion reactions, a harmonized and consistent approach to classification and definitions is imperative.  This presentation will review and demonstrate the use of current classification guidelines.


8:30 a.m. - 9:30 a.m. - Ledin Lecture: These Are a Few of My Favorite (Blood Banking/Transfusion Medicine) Things. Christopher Gresens, MD (Bloodsource)

The presenter will share ten case studies and/or personal experiences that have been instrumental in helping him work successfully in the field of transfusion medicine.  While the discussion will be clinically oriented throughout, it also will have a decidedly humanistic (and in some cases humorous) bent as the presenter shares numerous recollections of his life as a “blood banker.”


10 a.m. - 11:30 a.m.

Scientific Session: Potpourri of Reference Lab Cases/Panel Regina (Gina) Leger, SBB (American Red Cross),  and Clinical Applications of Molecular Panel with Focus on D-genotyping. Gerald Sandler (Georgetown University) How Do I Implement RhD Genotyping in Transfusion Service. Chelsea Hayes, MD (Cedars Sinai) 

This session will focus on immunohematology and molecular RBC typing.  Reference laboratory experts will describe a series of interesting serological cases and also clinical applications of molecular RBC genotyping.  In addition, guidelines for the implementation of RhD genotyping by a transfusion service will be shared.

Leadership Session: Managing, Messaging and Motivating in Times of Change. Vicki Finson, and Susan Williams

This session presents both the theoretical and applied aspects of managing and motivating staff.  Speakers will provide practical solutions and relevant examples from present-day case studies.


1:30 p.m. - 3 p.m.

Scientific Session: Sickle Cell Patient Management from Childhood to Adulthood. Anne Marsh, MD (CHO) and Anemia Not RBC Transfusion is Associated with NEC. Ajay Perambuti (CHLA).

The focus of this session is pediatric transfusion medicine.  Speakers will review the long term management of sickle cell patients.  Many sickle cell patients are well managed during childhood.  However the transition from pediatric to adult medicine can be challenging and has led to unwanted side effects from long term transfusion therapy and gaps in continued care.

 The session will also include a discussion on necrotizing enterocolitis (NEC) and recent evidence that supports its association with anemia rather than transfusion.

Administrative/Donor Resources Session, pt 1:  Performance Mgmt and Coaching Employees for Performance and Career Development. Susan William and Amy Hutch

Speakers will provide techniques and examples for coaching staff at all levels for specific performance improvement and career development

Administrative/Donor Resources Session, pt 2: The Brand You. Candace Judson

A fun and interactive presentation exploring the importance and implications of one's personal brand and what that lends to employee engagement, management, personal/professional development, and transferable skill sets necessary in any discipline. 


3:30 p.m. - 5 p.m.

Scientific Session:  Case Studies: Breast Milk and HDFN - Marissa Li, MD, Fatal Drug Induced Hemolytic Anemia from Piperacillin Lauren Eversmeyer, MD,  Passenger Lymphocyte Syndrome Post TransplantJean Soonmyong Oak, MD, PhD, Secondary Hemophegaocytic Lymphohistiocytosis in a Patient with Renal Cancer - Minh-Ha Tran, DO 

Breast milk has been reported to provide passive antibody mediated protection to newborns. In the case of a mother with high titer anti-D and an Rh-positive newborn, this passive acquisition of maternal antibodies led to prolonged hemolytic anemia in the newborn.

Drug-induced hemolysis may cause significant morbidity and mortality depending on the patient’s underlying condition, susceptibility, quantity, and dosing frequency of the drug.

Passenger lymphocytes from solid organs containing high volume of blood may cause delayed hemolysis in the recipient.

Hemophagocytosis is a rare condition with over activation of macrophages and numerous downstream immunologic complications. 

Quality, Safety and Compliance Session: ABCs of BPDs. Karen Dosanjh; and CA State Biologics License. Ann Sintef 

The speaker will discuss common questions about Biological Product Deviations (BPDs)-- What qualifies as a BPD? Who sees them at the FDA? Will the FDA come to inspect us because of our BPDs? – plus many others.  In addition, root cause process improvement will be discussed.

The speaker will discuss CA state biological licenses and how they differ from FDA registration. MLTscope of practice, 5 day plasma, and 7 day platelets will be discussed as well.



8 a.m. - 8:30 a.m.

Pre-Perkins Lecture: Update on Innovative Blood Products. Shibani Pati (BSRI)

Multiple new blood products are currently being studied both in vitro and in vivo and offer alternatives to blood products currently available. Three promising new products include cold stored platelets, lyophilized platelets, and lyophilized plasma. This presentation provides an update on these innovative products.

8:30 a.m. - 9:30 a.m.

Perkins Lecture: Transfusion Medicine Since 1978: A Personal Journey. Pearl Toy, MD

During this Award Lecture, the speaker will share memorable challenges faced during a long career in transfusion medicine, which provided opportunities to change and advance the field.   The speaker will focus on three specific challenges she experienced including Human Immunodeficiency Virus, Hepatitis B Virus, and Transfusion Related Acute Lung Injury. 


10 a.m. - 11:30 a.m. 

Scientific Session:  Blood ManagementUpdate on New Targeted Oncology Treatments and Impact on Transfusion -Kanwarpal Kahlon, MD and Hemoglobin Based Oxygen Carriers aka Artificial Blood - Salima Shaikh MD

This Blood Management related session will review new more targeted drugs for hematologic malignancies and changes in conditioning regimens which may decrease the need for blood products.  Artificial blood options that are currently being studied will also be reviewed.

Nursing Session: Best Practices from a Crisis Situation. Joy Fridey, MD and The San Bernardino Shooting: A Crisis Management Case Study. W. Tait Stevens, MD

The speaker will present an overview of the coordination of activities of CBBS Institutional Members in the event of a local, regional, or national blood emergency.  

This presentation will review the coordination of activities from a Blood Bank’s perspective during a real event and the lessons learned.


1:30 p.m. - 3 p.m.

Scientific Session: Cellular Therapy: CAR T-cells - Promising New Cellular Therapy Leslie Poppelwell, MD and Stem Cell Gene Therapy for Treatment of Sickle Cell Disease and Immunodeficiency - Mark Walters, MD (CHO) 

Cellular immunotherapy uses immune cells to target and treat diseases.  CAR T-cells are engineered T-cells with chimeric antigen receptors.  Currently, clinical trials are investigating the use of CAR T-cells to treat different hematologic malignancies. 

Stem cell gene therapy is another new treatment option for diseases caused by a defective gene.  A functional gene can be inserted into the patient’s own stem cells and introduced back into the patient to cure the disease. Stem cell gene therapy has been successfully used to treat Severe Combined Immunodeficiency (SCID) and holds promise for the treatment of other diseases such as sickle cell disease.    

Nursing Session:  Donor Reactions Documentation and Donor Hemovigilance. Mary Townsend, MD

Using two case studies, the speaker will illustrate how to determine donors should be prevented from donating again based on the severity of their donor reactions.

The speaker will identify three best practices to assess and evaluate severity of donor reactions.


3:30 p.m. - 5 p.m.

JOINT SESSION: Ask the Experts

Selected speakers from conference will answer questions from attendees.




8 a.m. - 9:30 a.m.

Scientific Session: ZIKA Update Panel. James Watt, MD, PhD, Graham Simmons, PhD, Lou Katz, MD; and Review of the NEW FDA Final Guidance on Bacterial Contamination. Catherine Mazzei, MD

Zika infection became a globe health crisis due to its devastating impact on pregnant women and their children. Scientific evidence has substantiated the cause and effect relationship of intrauterine Zika infection and impact on neuro development. Zika virus has also been demonstrated to survive in donated blood components, the US blood collection agencies along with its regulatory bodies rapidly developed risk mitigation strategies including additional donor questionnaire and testing.

Bacterially contaminated platelets remain a significant concern for transfusion related adverse events.  FDA has published a Draft Guidance on this issue with some suggestion that could have tremendous impact for both the blood center and hospital transfusion service


9:45 a.m. - 11:15 a.m.

Scientific and Quality, Safety Compliance Combined Session: Transfusion Service and Blood Center Partnerships. Suchitra Pandey, MD, Theresa Dunning, MSQA, MT (ASCP)SBB, CMQ/OE(ASQ)

Given the regulatory and scientific complexity of modern blood banking, most hospital transfusion services rely on an outside blood center for the procurement of blood for transfusion. This session will discuss ways that hospital-based transfusion services can benefit from a close relationship with their blood suppliers relating to management of patients and quality assurance.

Management of a large recall event will also be described from the hospital perspective since it provides a good example of a successful partnership between the Blood Center and the hospital Transfusion Service.  


11:15 a.m. - 12:15 p.m.

 JOINT CLOSING KEYNOTE: The Changing World of Transfusion Medicine: To Infinity and Beyond. Lou Katz, MD

We are currently experiencing rapid change in the field of transfusion medicine.  Dr. Katz will present current challenges that affect the present and the future of donor centers and transfusion services.  He will also present possible solutions that could lead us to more stability in the field.


Membership Management Software Powered by YourMembership  ::  Legal